
Bioorganic and Medicinal Chemistry Letters p. 3577 - 3582 (1998)
Update date:2022-08-04
Topics:
Chambers
Antognoli
Cheng
Kuperman
Liston
Marfat
Owens
Pillar
Shirley
Watson
A new series of cysLT1 receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT1 receptor antagonists Zafirlukast (1) and Pranlukast (2).
View MoreContact:+86-0512-88957371
Address:shanghai
Contact:86-574-26865651
Address:529 YuanBaoShan Road, Beilun District
Contact:86-379-63338609
Address:Jiudian Village,Deting Town,Song County,Luoyang
Tianjin Emulsion Science&Technology Development Co.,Ltd
Contact:13901380442
Address:Vake Garden New Town New Yi Bai Road Beichen District Tianjin,China
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
Doi:10.1021/ja4098803
(2013)Doi:10.1021/ja00217a003
(1988)Doi:10.1016/j.tetlet.2013.10.156
(2014)Doi:10.1021/ja056505c
(2006)Doi:10.1016/j.tet.2020.131635
(2020)Doi:10.1002/ejoc.201801318
(2018)